BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11940464)

  • 1. [The hypoxia-inducible factor HIF as a new target in cancer research].
    L'Allemain G
    Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
    Vandenbunder B
    Bull Cancer; 1998 Oct; 85(10):843-5. PubMed ID: 9835861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.
    Damert A; Machein M; Breier G; Fujita MQ; Hanahan D; Risau W; Plate KH
    Cancer Res; 1997 Sep; 57(17):3860-4. PubMed ID: 9288800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.
    Liu LX; Lu H; Luo Y; Date T; Belanger AJ; Vincent KA; Akita GY; Goldberg M; Cheng SH; Gregory RJ; Jiang C
    Biochem Biophys Res Commun; 2002 Mar; 291(4):908-14. PubMed ID: 11866451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.
    Ozawa K; Kondo T; Hori O; Kitao Y; Stern DM; Eisenmenger W; Ogawa S; Ohshima T
    J Clin Invest; 2001 Jul; 108(1):41-50. PubMed ID: 11435456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
    Fang J; Yan L; Shing Y; Moses MA
    Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia--a key regulatory factor in tumour growth.
    Harris AL
    Nat Rev Cancer; 2002 Jan; 2(1):38-47. PubMed ID: 11902584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.
    Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I
    Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity.
    Iervolino A; Trisciuoglio D; Ribatti D; Candiloro A; Biroccio A; Zupi G; Del Bufalo D
    FASEB J; 2002 Sep; 16(11):1453-5. PubMed ID: 12205045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.
    Makino Y; Cao R; Svensson K; Bertilsson G; Asman M; Tanaka H; Cao Y; Berkenstam A; Poellinger L
    Nature; 2001 Nov; 414(6863):550-4. PubMed ID: 11734856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
    Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
    Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building better vasculature.
    Bruick RK; McKnight SL
    Genes Dev; 2001 Oct; 15(19):2497-502. PubMed ID: 11581154
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
    Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neovasculation in ischemic heart disease].
    Minamino T; Komuro I
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():154-60. PubMed ID: 12734969
    [No Abstract]   [Full Text] [Related]  

  • 18. Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts.
    Abraham D; Krenn K; Seebacher G; Paulus P; Klepetko W; Aharinejad S
    Ann Thorac Surg; 2004 May; 77(5):1751-5. PubMed ID: 15111179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoxia and angiogenesis].
    Simon JM
    Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.
    Acker T; Plate KH
    Cell Tissue Res; 2003 Oct; 314(1):145-55. PubMed ID: 12898211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.